Edaravon
Products For ALS treatment, edaravone was approved in Japan in 2015 (Radicut) and in the United States in 2017 as an infusion product (Radicava). In the EU, edaravone has orphan drug status. In many countries, the drug has been registered since 2019. Structure and properties Edaravone (C10H10N2O, Mr = 174.2 g/mol) is a substituted 2-pyrazolin-5-one. … Edaravon
